[SLN] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 170.67%
YoY- 205.12%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 1,988 122 0 0 385 0 4 181.17%
PBT -9,540 -6,636 -5,370 1,441 -2,410 -2,644 -3,178 20.08%
Tax -462 950 507 508 557 1,392 446 -
NP -9,078 -5,686 -4,862 1,949 -1,854 -1,252 -2,732 22.13%
Tax Rate - - - -35.30% - - - -
Total Cost 11,066 5,808 4,862 -1,949 2,239 1,252 2,736 26.19%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -456.64 -4,660.66 0.00 0.00 -481.43 0.00 -68,300.00 -56.56%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.33 -0.22 -0.21 0.08 -0.08 -0.05 -0.16 12.81%
EPS Diluted -0.33 -0.22 -0.21 0.08 -0.08 -0.05 -0.16 12.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.